| http://www.w3.org/ns/prov#value | - ies on four continents after three years of preparation and broad consultation with the community, national authorities and other stakeholders following good participatory practices (GPP) and ethical principles in biomedical research as recommended by UNAIDS/WHO. The iPrEx trial is rolling over participants on an open label extension observational study where participants will receive active FTC/T
|
